Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Sets New 52-Week High – What’s Next?

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY)’s stock price hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $10.2750 and last traded at $10.04, with a volume of 5791 shares traded. The stock had previously closed at $9.94.

Shionogi & Co., Ltd. Unsponsored ADR Trading Up 1.0%

The company has a debt-to-equity ratio of 0.01, a current ratio of 6.44 and a quick ratio of 5.74. The company has a market capitalization of $17.39 billion, a price-to-earnings ratio of 15.97, a P/E/G ratio of 2.10 and a beta of 0.19. The business’s 50-day moving average price is $9.01 and its two-hundred day moving average price is $8.72.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last issued its quarterly earnings results on Friday, January 30th. The company reported $0.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.19 by $0.09. The business had revenue of $966.53 million for the quarter, compared to the consensus estimate of $848.42 million. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 11.90% and a net margin of 39.53%. Research analysts predict that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 earnings per share for the current year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.